Xenon protects left ventricular diastolic function during acute ischemia, less than ischemic preconditioning
Jan-H Baumert1, Anna B Roehl2, Sandra Funcke2
1Department of Anesthesiology, Intensive Care and Pain Medicine, KRH Klinikum Nordstadt, Hannover, Germany.
Medical Gas Research
|November 22, 2016
Summary
Xenon anesthesia limited global diastolic dysfunction during acute myocardial ischemia, similar to ischemic preconditioning. This study highlights xenon
Area of Science:
- Cardiology
- Anesthesiology
- Physiology
Background:
- Anesthetics' effects on global left ventricular (LV) function during ischemia/reperfusion are not fully understood.
- Regional LV dysfunction is known to be modified by anesthetics, but global impacts require further investigation.
Purpose of the Study:
- To test if xenon limits global LV dysfunction caused by acute anterior wall ischemia.
- To compare xenon's effects to ischemic preconditioning in preserving cardiac function.
Main Methods:
- Utilized an open-chest pig model with 60-minute LAD coronary artery occlusion and 120-minute reperfusion.
- Administered xenon inhalation throughout the procedure in one group, comparing it to control and ischemic preconditioning groups.
- Assessed load-independent diastolic and systolic function using pressure-volume relations and recorded hemodynamic parameters.
Main Results:
- Ischemia impaired global diastolic function in controls, with partial recovery during reperfusion.
- Xenon limited diastolic dysfunction during ischemia, while preconditioning abolished it.
- Global systolic function was preserved in all groups despite significant ischemic burden (40% LV mass).
Conclusions:
- Xenon anesthesia effectively limits global diastolic dysfunction during acute myocardial ischemia.
- Ischemic preconditioning provides complete protection against ischemia-induced diastolic dysfunction.
- Global systolic function remains preserved under these experimental conditions, underscoring the importance of diastolic function assessment.


